Yuanbao Inc.(YB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

YB Yuanbao Inc.

Market Closed 10-30 16:00:00 EDT

11.20

-0.25

-2.18%

盘后11.20

+0.000.00%

16:19 EDT

High11.43	Low11.20	Vol3.21K
Open11.31	D1 Closing11.45	Amplitude2.01%
Mkt Cap516.10M	Tradable Cap91.85M	Total Shares46.08M
T/O36.46K	T/O Rate0.04%	Tradable Shares8.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"YB","market":"US","secType":"STK","nameCN":"Yuanbao Inc.","latestPrice":11.2,"timestamp":1793390400000,"preClose":11.45,"halted":0,"volume":3205,"hourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":11.2,"latestTime":"16:19 EDT","volume":100,"amount":1136.41,"timestamp":1793391540466,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02183406113537118,"floatShares":8200500,"shares":46080200,"eps":4.570043,"marketStatus":"Market Closed","change":-0.25,"latestTime":"10-30 16:00:00 EDT","open":11.31,"high":11.43,"low":11.2,"amount":36455,"amplitude":0.020087,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.570043,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793610000000},"marketStatusCode":7,"adr":0,"adrRate":6,"listingDate":1745985600000,"exchange":"NASDAQ","adjPreClose":11.45,"dividendRate":0.112625,"postHourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":11.2,"latestTime":"16:19 EDT","volume":100,"amount":1136.41,"timestamp":1793391540466,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.18900972037538694},"requestUrl":"/m/hq/s/YB/tweets","defaultTab":"tweets","newsList":[{"id":"1150171123","title":"Hashrate Hurdle Rises 4.7%: Bitcoin Must Clear $82,900 to Preserve Miner Margins","url":"https://stock-news.laohu8.com/highlight/detail?id=1150171123","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150171123?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:55","pubTimestamp":1789480532,"startTime":"0","endTime":"0","summary":"Following a profitable August marked by price gains and stronger mining revenue, the Bitcoin network now faces a formidable headwind from an imminent difficulty adjustment. Analysts at Luxor note...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKB","BK4601","YBIT","ARKY","BITW","HECO","BITO","GDLC","WGMI","CBTO","EZBC","BTC","BITB","BETE","03042","BK1611","CBTJ","MSDD","BITX","MSST","03439","BETH","BTGD","HODL","TXXH","STCE","BRRR","BPI","07799","GBTC","IBIT","BK4594","CBOA","MSBT","CBOO","BITY","09008","CBXY","CBOY","09439","BITQ","SMST","YB","CRPT","IMST","DFII","CBXJ","MSTZ","QBF","MAXI","BTCW","CBXA","MST","MSTU","BITC","XBTY","BCCC","NCIQ","MSII","DAPP","09042","BK4588","BK4585","OOQB","BTYB","BFAP","CBOJ","BITU","GCPU","03008","YBTC","CBTY","BTFX","BFJL","BTCC","MSTC","BAGY","WNTR","BTCZ","SBIT","NGHT","CBXO","MSTP","BTCL","MNRS","BITI","MSTX","MBTmain","BEGS","MSTW","MSTK","MSTY","DEFI","BKCH","FBTC","07399","CBTA","BTRN","BTCI","BTF","BTCO","BK4173","MTYY","83042","LFGY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666570309","title":"Yuanbao, Inc. Earnings Call Highlights AI-Led Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2666570309","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666570309?lang=en_us&edition=fundamental","pubTime":"2026-09-12 08:10","pubTimestamp":1789171856,"startTime":"0","endTime":"0","summary":"Yuanbao, Inc. Unsponsored ADR (($YB)) has held its Q2 earnings call. Read on for the main highlights of the call. Yuanbao, Inc. Unsponsored ADR del...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-led-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-led-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","AGIX","ARTY","VTHR","QTOC","YB","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560629","title":"Yuanbao Q2 FY26 Net Income Rises 35.6% to RMB 413.2 Million; Revenue Increases 30.1% to RMB 1.39 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560629","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560629?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:09","pubTimestamp":1789038558,"startTime":"0","endTime":"0","summary":"Yuanbao Q2 FY26 net income rises 35.6% to RMB 413.2 million; revenue increases 30.1% to RMB 1.39 billionYuanbao posted Q2 2026 revenue of RMB 1.39 billion, up 30.1% year over year.Net income climbed 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLb0YPLd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666234564","title":"Yuanbao Q2 Adj. EPS $1.32 Up From $0.97 YoY, Sales $205.182M Up From $149.356M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2666234564","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666234564?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:01","pubTimestamp":1789034497,"startTime":"0","endTime":"0","summary":"Yuanbao (NASDAQ:YB) reported quarterly earnings of $1.32 per share. This is a 36.08 percent increase over earnings of $0.97 per share from the same period last year.  The company reported $205.182 million in sales this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61706785/yuanbao-q2-adj-eps-1-32-0-97-yoy-sales-205-182m-149-356m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666797564","title":"Yuanbao - Q2 2026 Total Revenues up 30.1% to Rmb1,392.2 Mln (us$205.2 Mln)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666797564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666797564?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:00","pubTimestamp":1789034401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUABLNY1X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666641175","title":"Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2666641175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666641175?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:00","pubTimestamp":1789034401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUABLNY1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353207","title":"Yarrow Bioscience’s YB-101 Trial Targets Graves’ Disease, Raising New Investor Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353207","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353207?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:30","pubTimestamp":1788539458,"startTime":"0","endTime":"0","summary":"Yarrow Bioscience, Inc. ($YARW) announced an update on their ongoing clinical study. The phase 2 study “A Randomized, Blinded, Placebo-Controlled, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yarrow-biosciences-yb-101-trial-targets-graves-disease-raising-new-investor-interest?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yarrow-biosciences-yb-101-trial-targets-graves-disease-raising-new-investor-interest?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875893","title":"Yuanbao to Report Q2 2026 Results, Host Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875893?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:00","pubTimestamp":1788429635,"startTime":"0","endTime":"0","summary":"Yuanbao to Report Q2 2026 Results, Host Earnings CallYuanbao will report Q2 2026 unaudited financial results on Thursday, Sept. 10, 2026, before the U.S. market open.Management earnings call set for 8","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3GbnPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210150020.SGD","BCDF","SG9999014039.USD","IE00BQXX3C00.GBP","BK4585","BK4173","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","YB","LU0314104364.USD","SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","LU2095319765.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4112","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","NDAQ","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875568","title":"Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875568","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875568?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:00","pubTimestamp":1788429600,"startTime":"0","endTime":"0","summary":"BEIJING, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it will rel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355714/0/en/yuanbao-inc-to-announce-second-quarter-2026-financial-results-on-thursday-september-10-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065979","title":"YB Ventures Malaysia 4th-Quarter 2026 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065979?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:36","pubTimestamp":1787909760,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                      13,593,000         15,677,000. PreTax Profit                -3,827,000        -44,830,000. Net Profit                   -7,699,000        -46,955,000. Earnings Per Share            -2.63 Sen         -16.09 Sen. Dividend                       0.00 Sen           0.00 Sen. Revenue                      50,258,000         64,868,000. PreTax Profit               -28,163,000        -63,178,000. Net Profit                  -32,087,000        -65,364,000. Earnings Per Share           -10.98 Sen         -22.39 Sen. Dividend                       0.00 Sen           0.00 Sen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659733155","title":"Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659733155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659733155?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"--  The Company initiated the Phase 2a/2b trial of YB-101 in patients with. Graves' disease , with or without concurrent thyroid eye disease. --  The Phase 2a portion of the trial is a randomized,four cohorts designed to evaluate safety, pharmacokinetics ,pharmacodynamics , and efficacy over 24 weeks, including the. percentage of patients who are euthyroid and off anti-thyroid. drugs, as well as relevant measures of orbitopathy in patients. --  Topline results from the Phase 2a portion of the trial are. --  The Phase 2b portion of the trial is expected to commence in the. --  Licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDEF","BK4007","KBWY","PD","YARW","WDGF","BK4023","BK4181","GD","BK4585","BK4516","LU1169589451.USD","BK4187","SHLD","LU0170899867.USD","PK","BK4173","BK4218","LU1169590202.USD","FOWF","BK4550","YB","PPA","TSHR","BK4566","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654188596","title":"Yarrow Bioscience initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2654188596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654188596?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:05","pubTimestamp":1785251123,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku initiated coverage of Yarrow Bioscience (YARW) with a Buy rating. YB-101 is the leading anti-thyroid stimulating hormone ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yarrow-bioscience-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yarrow-bioscience-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","BK4566","BK4127","TD","YB","COWN","GSIB","BK4207","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172460343","title":"Yarrow Bioscience Finalizes Merger with VYNE, Starts Phase 2 Trial for Graves' Disease Drug YB-101","url":"https://stock-news.laohu8.com/highlight/detail?id=1172460343","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172460343?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:01","pubTimestamp":1785160880,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company Yarrow Bioscience announced today that it has completed its merger with VYNE Therapeutics, simultaneously closing a roughly $200 million private placement...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB","BK4173","YARW","VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654043338","title":"Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2654043338","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654043338?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:17","pubTimestamp":1785158242,"startTime":"0","endTime":"0","summary":"Yarrow Bioscience  said Monday that it has completed its merger with VYNE Therapeutics and the previously announced private financings totaling approximately $200 million.The combined company will operate as Yarrow Bioscience and its shares are expected to begin trading on the Nasdaq Capital Market on Tuesday under the ticker symbol YARW.The combined company will be led by President and Chief Executive Officer Rebecca Frey, Chief Operating Officer Rachael Alford, and Chief Financial Officer Tyler Zeronda.Bill Lundberg, former chief executive of biotech firm Merus, will become chairman of the board of directors.Yarrow said its lead product candidate, YB-101, is a potential first-in-class anti-thyroid-stimulating hormone receptor monoclonal antibody designed to directly disrupt the central mechanism driving both Graves' disease and thyroid eye disease in a single targeted treatment.The company also said it has initiated dosing in a Phase 2a/2b trial of YB-101 in patients with Graves' dis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","VYNE","YB","YARW","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654145380","title":"Press Release: Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of Yb-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2654145380","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654145380?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150000,"startTime":"0","endTime":"0","summary":"Yarrow is advancing YB-101--a potential first-in-class anti-TSHR antibody, designed to directly disrupt the central mechanism driving both Graves' disease (\"GD\") and thyroid eye disease (\"TED\")Dosing ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","YB","BK4007","BK4173","YARW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562430","title":"Stocks Ex-dividend July 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562430","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562430?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:56","pubTimestamp":1782852960,"startTime":"0","endTime":"0","summary":"Gl Net Lease Pfd. A           GNLpA        8.0     0.45313. Glbl Net Lease Pfd D          GNLpD        8.1     0.46875. Global Net Lease Pfd E        GNLpE        8.1     0.46094. Global Net Lease Pfd. B       GNLpB        8.0     0.42969. Source: FactSet Dow Jones NewswiresJune 30, 2026 16:56 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","YB","VIG","BK4585","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642585258","title":"Yuanbao, Inc. Earnings Call Highlights AI-Powered Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2642585258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642585258?lang=en_us&edition=fundamental","pubTime":"2026-06-12 08:12","pubTimestamp":1781223149,"startTime":"0","endTime":"0","summary":"Yuanbao, Inc. Unsponsored ADR (($YB)) has held its Q1 earnings call. Read on for the main highlights of the call. Yuanbao, Inc. Unsponsored ADR del...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-powered-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-powered-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","CHAT","AGIX","ARTY","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423455","title":"Yuanbao Inc. Posts Strong Q1 2026 Results and Deepens AI Push in Online Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423455?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:39","pubTimestamp":1781091572,"startTime":"0","endTime":"0","summary":"The latest update is out from Yuanbao, Inc. Unsponsored ADR ( ($YB) ). Yuanbao Inc., a Chinese technology-driven online insurance distributor, repo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-posts-strong-q1-2026-results-and-deepens-ai-push-in-online-insurance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-posts-strong-q1-2026-results-and-deepens-ai-push-in-online-insurance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","YB","AIPO","BK4173","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642045447","title":"Yuanbao to remain focused  on high-quality revenue growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2642045447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642045447?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:17","pubTimestamp":1781086651,"startTime":"0","endTime":"0","summary":"Ray Wan, CFO of Yuanbao (YB), said, “In the Q1, we delivered another strong performance, driven by our continued business expansion and operating e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-to-remain-focused-on-high-quality-revenue-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-to-remain-focused-on-high-quality-revenue-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642244770","title":"Yuanbao announces $15M share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2642244770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642244770?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:16","pubTimestamp":1781086589,"startTime":"0","endTime":"0","summary":"The Company announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $15M of it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-announces-15m-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-announces-15m-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.yuanbaobaoxian.cn","stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":-0.0997},{"period":"3month","weight":-0.1667},{"period":"6month","weight":-0.3162},{"period":"1year","weight":-0.514},{"period":"ytd","weight":-0.4472}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":-0.0091},{"period":"3month","weight":0.0116},{"period":"6month","weight":0.0487},{"period":"1year","weight":0.1116},{"period":"ytd","weight":0.1082}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Yuanbao, Inc. operates as a holding company, which provides online insurance distribution and services. Its products include million medical insurance, comprehensive accident insurance, and major disease insurance. The company was founded by Rui Fang in December 2019 and is headquartered in Beijing, China.","exchange":"NASDAQ","name":"Yuanbao Inc.","nameEN":"Yuanbao Inc.","securityTypeName":"DR","adrRate":"1:6"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Yuanbao Inc.(YB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Yuanbao Inc.(YB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Yuanbao Inc.,YB,Yuanbao Inc.股票,Yuanbao Inc.股票老虎,Yuanbao Inc.股票老虎国际,Yuanbao Inc.行情,Yuanbao Inc.股票行情,Yuanbao Inc.股价,Yuanbao Inc.股市,Yuanbao Inc.股票价格,Yuanbao Inc.股票交易,Yuanbao Inc.股票购买,Yuanbao Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Yuanbao Inc.(YB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Yuanbao Inc.(YB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction